This document describes the particular clinical laboratory practice requirements to ensure the quality of detection, identification and quantification of microbial pathogens using nucleic acid amplification tests (NAAT).
It is intended for use by laboratories that develop, and/or implement and use, or perform NAAT for medical, research or health-related purposes. This document does not apply to the development of in vitro diagnostic (IVD) medical devices by manufacturers. However, it does include verification and validation of such devices and/or the corresponding processes when implemented and used by the laboratories.
Status: PublishedPublication date: 2020-11
Corrected version (en): 2020-12
Edition: 1Number of pages: 39
Technical Committee: ISO/TC 212 Clinical laboratory testing and in vitro diagnostic test systems
- ICS :
- 11.100.01 Laboratory medicine in general
This standard contributes to the following Sustainable Development Goal:
Buy this standard
|std 1 166||PDF + ePub|
|std 2 166||Paper|
ISO 17822:2020Stage: 60.60
Got a question?
Check out our FAQs
Monday to Friday - 09:00-12:00, 14:00-17:00 (UTC+1)
Keep up to date with ISO
Sign up to our newsletter for the latest news, views and product information.